The construction of new hybridoma cell lines producing monoclonal antibodies, construction of fluorochrome labelled antibodies for diagnostic purposes, and certification of selected reagents as in-vitro diagnostics.
An innovative technology for robust high-productivity processes will be established and scaled-up. A compendium of the knowledge gathered regarding mixed substrate cultivation will be made available.
Signalling proteins will be prepared using recombinant techniques and used for making poly and monoclonal antibodies. Antibodies to cell surface receptors will be labelled using modern fluorochromes. These products will be marketed by the czech biotech company exbio.
Research and development by russian orthopedists into a method for surgically repairing birth defects of the skeleton, particularly those affecting the length of the extremities.
Experimental production of prototype radioimmunology reagents based on engineered antibodies harbouring all desired properties (e.G. Affinity, stability, non-immunogenicity and high levels of labelling) in combination.
New elisa kits for detection of environmental pollutants on the basis of new monoclonal antibodies
The development of a new modular system. The production of a new laboratory device. The final result of this project should be a fully automatic serologic system. This system will be designed for clinical and research laboratories.
Development and processing of molecular-biological diagnostic kits for rapid and sensitive diagnosis of viruses and bacteria causing human and animal diseases.
Environmentally friendly semi solid preparation from natural ecological sources will be created. This qualitatively new cream will retard cell aging, strengthen the antimicrobial barrier of the skin and promote healthy healing.
The aim is non-invasive measuring of cardiovascular respiratory and autonomic nervous system dynamics. The systolic force, minute cardiac force, heart rate, variability of the heart rhythm and respiratory frequency are all measured.